<!DOCTYPE html>
<html>
<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	 <link rel="stylesheet" href="style.css">
	<title>Module 2 Solution</title>
</head>
<body>
<div class="vaccine">
<h1>Covid Vaccines</h1>

  <div class="col-lg-4 col-md-6 col-sm-12" id="section">
    <p id="p1">Covaxin</p>
    <p>Covaxin (codenamed as BBV152) is an inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. As an inactivated vaccine, Covaxin uses a more traditional technology that is similar to the inactivated polio vaccine. It is a 2-dose vaccination regimen given 28 days apart.</p>
  </div>

  <div class="col-lg-4 col-md-6 col-sm-12" id="section">
    <p id="p2">Covishield</p>
    <p>The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed by Oxford University and AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus.</p>
  </div>

  <div class="col-lg-4 col-md-12 col-sm-12" id="section">
    <p  id="p3">Sputnik V</p>
    <p>Sputnik V (Russian: Спутник V) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology. The 'V' in its name is the letter and not the Roman numeral. Dr Reddy's has started inoculation with Russia's Sputnik V as part of the soft launch in India. </p>
  </div>

</div>	
</body>
</html>